Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

Reichstetter S, Castillo GM, Lai M, Nishimoto-Ashfield A, Banerjee A, Bogdanov A, Lyubimov AV, Bolotin EM.

Pharm Res. 2012 Apr;29(4):1033-9. doi: 10.1007/s11095-011-0646-8. Epub 2011 Dec 28.

PMID:
22203325
2.

Concentrated insulin glargine (Toujeo) for diabetes.

[No authors listed]

Med Lett Drugs Ther. 2015 May 11;57(1468):69-70. Review.

PMID:
25941955
3.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
4.

[Safety of insulin analogues: what to evaluate, how to do it, and how to interpret the results].

Hernández Mijares A, Solá Izquierdo E, García Malpartida K, Verge D.

Endocrinol Nutr. 2010 Oct;57(8):376-80. doi: 10.1016/j.endonu.2010.05.001. Review. Spanish.

PMID:
20621572
5.

An overview of insulin glargine.

Home PD, Ashwell SG.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S57-63. Review.

PMID:
12324987
6.

Ultra-fast acting insulin analogues.

Kalra S, Gupta Y.

Recent Pat Endocr Metab Immune Drug Discov. 2014;8(2):117-23. Review.

PMID:
25022572
7.

Albumin as a drug delivery and diagnostic tool and its market approved products.

Sethi A, Sher M, Akram MR, Karim S, Khiljee S, Sajjad A, Shah SN, Murtaza G.

Acta Pol Pharm. 2013 Jul-Aug;70(4):597-600. Review.

Supplemental Content

Support Center